Sigma Healthcare Schedules FY26 Results Release Featuring New Segment Reporting

Segment Reporting Shift Reflects International Expansion

Sigma Healthcare Limited (ASX:SIG) is set to publish its FY26 financial results on 27 August, introducing a significant change in how it reports its business segments. For the first time, the company will split its operations into two distinct segments: Australia and International. This adjustment acknowledges the growing strategic importance and complexity of its international markets, which have expanded considerably following recent mergers and joint ventures.

The revision aims to provide investors with clearer insights into the differing financial and operational dynamics across these geographies. To assist with this transition, Sigma has released comparative FY25 segment data, allowing stakeholders to track performance trends under the new structure.

Normalised Results Adjusted for Merger and Integration Costs

Alongside the statutory profit figures, Sigma will present normalised profit and loss results for FY26 and FY25. These adjustments exclude merger-related costs incurred in FY25, integration expenses, and non-cash charges related to merger purchase price accounting. This approach is designed to offer a more representative view of underlying business profitability, stripping out one-off and non-operational impacts from the recent Chemist Warehouse merger.

FY26 revenue is expected to reflect the ongoing integration and expansion efforts, with the company reporting a gross profit of approximately $1.36 billion and total revenue near $5.69 billion across segments. The International segment, though smaller in absolute terms, is accounted for using the equity method, highlighting its emerging role within the group.

Investor Engagement Through Webcast Presentation

Sigma will host a webcast briefing at 10:00am AEST on the day of the results release, featuring a presentation followed by a live question and answer session. This format offers investors and analysts an opportunity to probe the details behind the numbers and management’s outlook amid the company’s evolving structure.

The company’s move to segment reporting underscores the strategic execution of its international growth ambitions, which have been bolstered by recent expansions into markets such as the UK and New Zealand. This shift also aligns with the broader integration progress post-merger, which has seen synergy targets increase and operational efficiencies pursued aggressively.